← Back to Search

Smart Vending Machines for HIV Self-Testing

N/A

Recruiting

Led By Sean B Rourke, PhD

Research Sponsored by Unity Health Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months

Awards & highlights

Study Summary

This trial program is providing free HIV self-testing kits and other harm reduction supplies to those who do not have access to healthcare, to break down barriers to testing & equip them with the resources they need. #EquityInHealth #I'mReady #OurHealthbox

Who is the study for?

This trial is for individuals aged 16 and older (18+ in Quebec) living in Canada who can consent in English or French. It's aimed at those without access to a phone for HIV self-testing, facing healthcare barriers like addiction, stigma, or chaotic lifestyles.Check my eligibility

What is being tested?

The 'Our Healthbox' program is being tested; it's an interactive vending machine that provides free HIV self-tests and harm reduction supplies with no need for a smartphone, aiming to reach undiagnosed individuals across Canada.See study design

What are the potential side effects?

Since this trial involves the use of a dispensing system rather than medication, there are no direct medical side effects. However, users should be aware of the emotional impact of receiving health-related results.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Providing access to harm reduction supplies

Reaching first time testers

Reaching the undiagnosed and connecting them to care

Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

All participants

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,345 Previous Clinical Trials

26,448,514 Total Patients Enrolled

Canadian Foundation for AIDS Research (CANFAR)OTHER

7 Previous Clinical Trials

2,186 Total Patients Enrolled

Public Health Agency of Canada (PHAC)OTHER_GOV

45 Previous Clinical Trials

92,133 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05516069 — N/A

Self-Harm Research Study Groups: Intervention

Self-Harm Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05516069 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05516069 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have signed up to take part in this research?

"Affirmative. The clinical trial is still open for recruitment, as indicated by the information on clinicaltrials.gov - this medical study was first posted on January 23rd 2023 and last updated on June 1st 2023. 5000 patients are required from a single location to complete it."

Answered by AI

Is the current research looking to add more participants?

"True, according to clinicaltrials.gov the trial is actively enrolling candidates. The experiment was first posted on January 23rd 2023 and recently modified on June 1st 2023. 5000 people are needed at a single site in order for this study to be successful."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.

2023. "Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05516069.